 | • レポートコード：MRC23Q36695 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のベンダムスチン塩酸塩粉末市場について調査・分析し、世界のベンダムスチン塩酸塩粉末市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（25mg/個、100mg/個）、用途別セグメント分析（病院、診療所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Cephalon、Viatris、Apotex、Dr. Reddy's Laboratories、Fresenius Kabi、Baxter、Nang Kuang Pharmaceutical、Chia Tai Tianqing Pharmaceutical、Jiangsu Simcere Pharmaceutical、Yangtze River Pharmaceutical Group、Sichuan Huiyu Pharmaceutical、Kindos Pharmaなどが含まれています。世界のベンダムスチン塩酸塩粉末市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ベンダムスチン塩酸塩粉末市場規模を推定する際に考慮しました。本レポートは、ベンダムスチン塩酸塩粉末の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ベンダムスチン塩酸塩粉末に関するビジネス上の意思決定に役立てることを目的としています。 ・ベンダムスチン塩酸塩粉末市場の概要 - 製品の定義 - ベンダムスチン塩酸塩粉末のタイプ別セグメント - 世界のベンダムスチン塩酸塩粉末市場規模：タイプ別分析（25mg/個、100mg/個） - ベンダムスチン塩酸塩粉末の用途別セグメント - 世界のベンダムスチン塩酸塩粉末市場規模：用途別分析（病院、診療所、その他） - 世界のベンダムスチン塩酸塩粉末市場規模予測（2018年-2029年） - ベンダムスチン塩酸塩粉末の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ベンダムスチン塩酸塩粉末市場の競争状況およびトレンド ・ベンダムスチン塩酸塩粉末の地域別市場規模 - 北米のベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - アメリカのベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - ヨーロッパのベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - アジア太平洋のベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - 中国のベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - 日本のベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - 韓国のベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - インドのベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - オーストラリアのベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - 中南米のベンダムスチン塩酸塩粉末市場規模（2018年-2029年） - 中東・アフリカのベンダムスチン塩酸塩粉末市場規模（2018年-2029年） ・タイプ別セグメント：25mg/個、100mg/個 - 世界のベンダムスチン塩酸塩粉末のタイプ別販売量（2018年-2023年） - 世界のベンダムスチン塩酸塩粉末のタイプ別売上（2018年-2023年） - 世界のベンダムスチン塩酸塩粉末のタイプ別価格 ・用途別セグメント：病院、診療所、その他 - 世界のベンダムスチン塩酸塩粉末の用途別販売量（2018年-2023年） - 世界のベンダムスチン塩酸塩粉末の用途別売上（2018年-2023年） - 世界のベンダムスチン塩酸塩粉末の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Cephalon、Viatris、Apotex、Dr. Reddy's Laboratories、Fresenius Kabi、Baxter、Nang Kuang Pharmaceutical、Chia Tai Tianqing Pharmaceutical、Jiangsu Simcere Pharmaceutical、Yangtze River Pharmaceutical Group、Sichuan Huiyu Pharmaceutical、Kindos Pharma ・産業チェーンと販売チャネルの分析 - ベンダムスチン塩酸塩粉末産業チェーン分析 - ベンダムスチン塩酸塩粉末の主要原材料 - ベンダムスチン塩酸塩粉末の販売チャネル - ベンダムスチン塩酸塩粉末のディストリビューター - ベンダムスチン塩酸塩粉末の主要顧客 ・ベンダムスチン塩酸塩粉末市場ダイナミクス - ベンダムスチン塩酸塩粉末の業界動向 - ベンダムスチン塩酸塩粉末市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Highlights
The global Bendamustine Hydrochloride Powder market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Bendamustine Hydrochloride Powder is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Bendamustine Hydrochloride Powder is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Bendamustine Hydrochloride Powder include Cephalon, Viatris, Apotex, Dr. Reddy’s Laboratories, Fresenius Kabi, Baxter, Nang Kuang Pharmaceutical, Chia Tai Tianqing Pharmaceutical and Jiangsu Simcere Pharmaceutical, etc. in 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Bendamustine Hydrochloride Powder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Bendamustine Hydrochloride Powder.
The Bendamustine Hydrochloride Powder market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Bendamustine Hydrochloride Powder market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Bendamustine Hydrochloride Powder manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Cephalon
Viatris
Apotex
Dr. Reddy’s Laboratories
Fresenius Kabi
Baxter
Nang Kuang Pharmaceutical
Chia Tai Tianqing Pharmaceutical
Jiangsu Simcere Pharmaceutical
Yangtze River Pharmaceutical Group
Sichuan Huiyu Pharmaceutical
Kindos Pharma
Segment by Type
25mg/Pcs
100mg/Pcs
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Bendamustine Hydrochloride Powder manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Bendamustine Hydrochloride Powder in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
1 Bendamustine Hydrochloride Powder Market Overview
1.1 Product Overview and Scope of Bendamustine Hydrochloride Powder
1.2 Bendamustine Hydrochloride Powder Segment by Type
1.2.1 Global Bendamustine Hydrochloride Powder Market Value Comparison by Type (2023-2029)
1.2.2 25mg/Pcs
1.2.3 100mg/Pcs
1.3 Bendamustine Hydrochloride Powder Segment by Application
1.3.1 Global Bendamustine Hydrochloride Powder Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Bendamustine Hydrochloride Powder Market Size Estimates and Forecasts
1.4.1 Global Bendamustine Hydrochloride Powder Revenue 2018-2029
1.4.2 Global Bendamustine Hydrochloride Powder Sales 2018-2029
1.4.3 Global Bendamustine Hydrochloride Powder Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Bendamustine Hydrochloride Powder Market Competition by Manufacturers
2.1 Global Bendamustine Hydrochloride Powder Sales Market Share by Manufacturers (2018-2023)
2.2 Global Bendamustine Hydrochloride Powder Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Bendamustine Hydrochloride Powder Average Price by Manufacturers (2018-2023)
2.4 Global Bendamustine Hydrochloride Powder Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Bendamustine Hydrochloride Powder, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Bendamustine Hydrochloride Powder, Product Type & Application
2.7 Bendamustine Hydrochloride Powder Market Competitive Situation and Trends
2.7.1 Bendamustine Hydrochloride Powder Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Bendamustine Hydrochloride Powder Players Market Share by Revenue
2.7.3 Global Bendamustine Hydrochloride Powder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Bendamustine Hydrochloride Powder Retrospective Market Scenario by Region
3.1 Global Bendamustine Hydrochloride Powder Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Bendamustine Hydrochloride Powder Global Bendamustine Hydrochloride Powder Sales by Region: 2018-2029
3.2.1 Global Bendamustine Hydrochloride Powder Sales by Region: 2018-2023
3.2.2 Global Bendamustine Hydrochloride Powder Sales by Region: 2024-2029
3.3 Global Bendamustine Hydrochloride Powder Global Bendamustine Hydrochloride Powder Revenue by Region: 2018-2029
3.3.1 Global Bendamustine Hydrochloride Powder Revenue by Region: 2018-2023
3.3.2 Global Bendamustine Hydrochloride Powder Revenue by Region: 2024-2029
3.4 North America Bendamustine Hydrochloride Powder Market Facts & Figures by Country
3.4.1 North America Bendamustine Hydrochloride Powder Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Bendamustine Hydrochloride Powder Sales by Country (2018-2029)
3.4.3 North America Bendamustine Hydrochloride Powder Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Bendamustine Hydrochloride Powder Market Facts & Figures by Country
3.5.1 Europe Bendamustine Hydrochloride Powder Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Bendamustine Hydrochloride Powder Sales by Country (2018-2029)
3.5.3 Europe Bendamustine Hydrochloride Powder Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Bendamustine Hydrochloride Powder Market Facts & Figures by Country
3.6.1 Asia Pacific Bendamustine Hydrochloride Powder Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Bendamustine Hydrochloride Powder Sales by Country (2018-2029)
3.6.3 Asia Pacific Bendamustine Hydrochloride Powder Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Bendamustine Hydrochloride Powder Market Facts & Figures by Country
3.7.1 Latin America Bendamustine Hydrochloride Powder Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Bendamustine Hydrochloride Powder Sales by Country (2018-2029)
3.7.3 Latin America Bendamustine Hydrochloride Powder Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Bendamustine Hydrochloride Powder Market Facts & Figures by Country
3.8.1 Middle East and Africa Bendamustine Hydrochloride Powder Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Bendamustine Hydrochloride Powder Sales by Country (2018-2029)
3.8.3 Middle East and Africa Bendamustine Hydrochloride Powder Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Bendamustine Hydrochloride Powder Sales by Type (2018-2029)
4.1.1 Global Bendamustine Hydrochloride Powder Sales by Type (2018-2023)
4.1.2 Global Bendamustine Hydrochloride Powder Sales by Type (2024-2029)
4.1.3 Global Bendamustine Hydrochloride Powder Sales Market Share by Type (2018-2029)
4.2 Global Bendamustine Hydrochloride Powder Revenue by Type (2018-2029)
4.2.1 Global Bendamustine Hydrochloride Powder Revenue by Type (2018-2023)
4.2.2 Global Bendamustine Hydrochloride Powder Revenue by Type (2024-2029)
4.2.3 Global Bendamustine Hydrochloride Powder Revenue Market Share by Type (2018-2029)
4.3 Global Bendamustine Hydrochloride Powder Price by Type (2018-2029)
5 Segment by Application
5.1 Global Bendamustine Hydrochloride Powder Sales by Application (2018-2029)
5.1.1 Global Bendamustine Hydrochloride Powder Sales by Application (2018-2023)
5.1.2 Global Bendamustine Hydrochloride Powder Sales by Application (2024-2029)
5.1.3 Global Bendamustine Hydrochloride Powder Sales Market Share by Application (2018-2029)
5.2 Global Bendamustine Hydrochloride Powder Revenue by Application (2018-2029)
5.2.1 Global Bendamustine Hydrochloride Powder Revenue by Application (2018-2023)
5.2.2 Global Bendamustine Hydrochloride Powder Revenue by Application (2024-2029)
5.2.3 Global Bendamustine Hydrochloride Powder Revenue Market Share by Application (2018-2029)
5.3 Global Bendamustine Hydrochloride Powder Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Cephalon
6.1.1 Cephalon Corporation Information
6.1.2 Cephalon Description and Business Overview
6.1.3 Cephalon Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Cephalon Bendamustine Hydrochloride Powder Product Portfolio
6.1.5 Cephalon Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Corporation Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Viatris Bendamustine Hydrochloride Powder Product Portfolio
6.2.5 Viatris Recent Developments/Updates
6.3 Apotex
6.3.1 Apotex Corporation Information
6.3.2 Apotex Description and Business Overview
6.3.3 Apotex Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Apotex Bendamustine Hydrochloride Powder Product Portfolio
6.3.5 Apotex Recent Developments/Updates
6.4 Dr. Reddy’s Laboratories
6.4.1 Dr. Reddy’s Laboratories Corporation Information
6.4.2 Dr. Reddy’s Laboratories Description and Business Overview
6.4.3 Dr. Reddy’s Laboratories Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Dr. Reddy’s Laboratories Bendamustine Hydrochloride Powder Product Portfolio
6.4.5 Dr. Reddy’s Laboratories Recent Developments/Updates
6.5 Fresenius Kabi
6.5.1 Fresenius Kabi Corporation Information
6.5.2 Fresenius Kabi Description and Business Overview
6.5.3 Fresenius Kabi Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Fresenius Kabi Bendamustine Hydrochloride Powder Product Portfolio
6.5.5 Fresenius Kabi Recent Developments/Updates
6.6 Baxter
6.6.1 Baxter Corporation Information
6.6.2 Baxter Description and Business Overview
6.6.3 Baxter Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Baxter Bendamustine Hydrochloride Powder Product Portfolio
6.6.5 Baxter Recent Developments/Updates
6.7 Nang Kuang Pharmaceutical
6.6.1 Nang Kuang Pharmaceutical Corporation Information
6.6.2 Nang Kuang Pharmaceutical Description and Business Overview
6.6.3 Nang Kuang Pharmaceutical Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Nang Kuang Pharmaceutical Bendamustine Hydrochloride Powder Product Portfolio
6.7.5 Nang Kuang Pharmaceutical Recent Developments/Updates
6.8 Chia Tai Tianqing Pharmaceutical
6.8.1 Chia Tai Tianqing Pharmaceutical Corporation Information
6.8.2 Chia Tai Tianqing Pharmaceutical Description and Business Overview
6.8.3 Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Chia Tai Tianqing Pharmaceutical Bendamustine Hydrochloride Powder Product Portfolio
6.8.5 Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
6.9 Jiangsu Simcere Pharmaceutical
6.9.1 Jiangsu Simcere Pharmaceutical Corporation Information
6.9.2 Jiangsu Simcere Pharmaceutical Description and Business Overview
6.9.3 Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Jiangsu Simcere Pharmaceutical Bendamustine Hydrochloride Powder Product Portfolio
6.9.5 Jiangsu Simcere Pharmaceutical Recent Developments/Updates
6.10 Yangtze River Pharmaceutical Group
6.10.1 Yangtze River Pharmaceutical Group Corporation Information
6.10.2 Yangtze River Pharmaceutical Group Description and Business Overview
6.10.3 Yangtze River Pharmaceutical Group Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Yangtze River Pharmaceutical Group Bendamustine Hydrochloride Powder Product Portfolio
6.10.5 Yangtze River Pharmaceutical Group Recent Developments/Updates
6.11 Sichuan Huiyu Pharmaceutical
6.11.1 Sichuan Huiyu Pharmaceutical Corporation Information
6.11.2 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride Powder Description and Business Overview
6.11.3 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Sichuan Huiyu Pharmaceutical Bendamustine Hydrochloride Powder Product Portfolio
6.11.5 Sichuan Huiyu Pharmaceutical Recent Developments/Updates
6.12 Kindos Pharma
6.12.1 Kindos Pharma Corporation Information
6.12.2 Kindos Pharma Bendamustine Hydrochloride Powder Description and Business Overview
6.12.3 Kindos Pharma Bendamustine Hydrochloride Powder Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Kindos Pharma Bendamustine Hydrochloride Powder Product Portfolio
6.12.5 Kindos Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Bendamustine Hydrochloride Powder Industry Chain Analysis
7.2 Bendamustine Hydrochloride Powder Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Bendamustine Hydrochloride Powder Production Mode & Process
7.4 Bendamustine Hydrochloride Powder Sales and Marketing
7.4.1 Bendamustine Hydrochloride Powder Sales Channels
7.4.2 Bendamustine Hydrochloride Powder Distributors
7.5 Bendamustine Hydrochloride Powder Customers
8 Bendamustine Hydrochloride Powder Market Dynamics
8.1 Bendamustine Hydrochloride Powder Industry Trends
8.2 Bendamustine Hydrochloride Powder Market Drivers
8.3 Bendamustine Hydrochloride Powder Market Challenges
8.4 Bendamustine Hydrochloride Powder Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer